Rytelewski M, Harutyunyan K, Mallampati S, Zal AM, Baran N, Cavazos A, Butler JM, Konplev S, Marszalek J, Andreeff M , Vinogradov S, Zal T, Konopleva M
Effects of quercetin on adiponectin-mediated insulin sensitivity in polycystic ovary syndrome: a randomized placebo-controlled double-blind clinical trial
TRIUMPH-4 (Phase 3, 68 weeks) 12mg dose: 28.7% weight loss (~71 lbs / 32 kg average) 9mg dose: 26.4% weight loss (~64 lbs / 29 kg average) Patients also saw 76% reduction in knee osteoarthritis pain Blood pressure reduced by 14 mmHg on average Source: ClinicalTrials.gov (TRIUMPH-4, NCT05931367) The TRIUMPH Phase 3 program includes 4 trials studying retatrutide for obesity, type 2 diabetes, and cardiovascular outcomes
Treatment with carnitines, L-arginine and N-acetylcysteine in patients affected by functional hypothalamic amenorrhea and metabolic changes
For instance, it induces the release of cytokines such as TNF-, IL-1, IL-6, and IL-12